ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Glucocortocoids"

  • 2020 American Transplant Congress

    Donor-Derived Cell-Free DNA is Not Influenced by Steroid Dosing in Heart Transplant Recipients

    J. Teuteberg1, S. Krim2, M. Shullo3, S. Jimenez1, H. Eisen4

    1Stanford University, Stanford, CA, 2Ochsner Medical Center, New Orleans, LA, 3West Virginia University, Morgantown, WV, 4Pennsylvania State University, Hershey, PA

    *Purpose: Gene expression profiling (GEP) was recognized as an alternative to biopsy for rejection surveillance in the 2010 International society for Heart and Lung Transplantation…
  • 2020 American Transplant Congress

    Steroid Withdrawal and Lymphocyte Subsets in Graft Capillary Blood versus Peripheral Blood in Low Immunological Risk Kidney Transplant Patients: Randomized, Parallel Group, Controlled Clinical Trial

    T. Vazquez Sanchez, A. Caballero, J. Alonso-Titos, V. Lopez, E. Sola, M. Cabello, E. Gutierrez Vilchez, M. Martínez-Esteban, P. Ruiz Esteban, J. Delgado, D. Hernandez

    Regional University Hospital, Malaga, Spain

    *Purpose: Whether steroid withdrawal can modulate the subclinical inflammatory response after a kidney transplant is unknown.*Methods: We undertook a controlled multicenter clinical trial involving 105…
  • 2020 American Transplant Congress

    Maintenance Steroids in the Setting of Alemtuzumab Induction Post-Kidney Transplant Increases Risk of Infection and Hospital Readmission

    A. R. Webb, A. A. Al-Bahou, A. J. Brueckner, A. T. Logan, R. S. Baliga, L. J. Bowman Anger

    Tampa General Hospital, Tampa, FL

    *Purpose: This study sought to assess the safety of steroid-containing maintenance immunosuppression in the setting of alemtuzumab (ALEM) induction.*Methods: Adult (>18 years) kidney transplant recipients…
  • 2020 American Transplant Congress

    Comparison of 4 vs 14 Days Early Steroid Withdrawal in Kidney Transplant Recipients

    O. Adebiyi, J. Chen, B. Brady, S. Mietz, T. Taber, D. Mishler, M. Yaqub, W. Goggins, A. Sharfuddin

    Indiana University, Indianapolis, IN

    *Purpose: The optimal duration, as well as the dose of the initial steroid use, is not known as it varies widely among institutions that have…
  • 2020 American Transplant Congress

    Graft versus Host Disease in Liver Transplant Recipients: A Case Series

    N. Joiner, J. Dietz, K. Nava-Estevanott, L. Kerbe

    Cleveland Clinic Florida, Weston, FL

    *Purpose: Graft Versus Host Disease (GvHD) is a serious and potentially fatal disease that is rarely observed in solid organ transplant recipients; however, we report…
  • 2020 American Transplant Congress

    Steroid Dependence at 1 Yr in Kidney Transplant Recipients Initiated on Early Steroid Withdrawal Protocol: Associated Risk Factors and Prognosis

    M. Yaqub, D. Mishler, T. Taber, A. Sharfuddin, W. Goggins, O. Adebiyi

    Indiana University, Indianapolis, IN

    *Purpose: Early steroid withdrawal (ESW) has become a stable immunosuppression regimen in the USA with a third of patients now discharged steroid-free immediately post-transplant. However,…
  • 2019 American Transplant Congress

    Early Steroid Withdrawal in African American Deceased Donor Renal Transplant Recipients with Alemtuzumab Induction: Is Graft Loss on the Horizon?

    R. Lynn, B. Ravichandran, T. Sparkes, A. Haririan, J. Bromberg, J. Casale

    University of Maryland Medical Center, Baltimore, MD

    *Purpose: The safety of early steroid withdrawal (ESW) in African American (AA) deceased donor renal transplant recipients (DDRTs) is unclear. This study assessed the impact…
  • 2019 American Transplant Congress

    Belatacept Based Simultaneous Calcineurin Inhibitor Avoidance/Early Corticosteroid Withdrawal is Associated with Low New Onset Diabetes Risk

    A. R. Shields1, P. West-Thielke2, E. S. Woodle1, D. B. Kaufman3, J. Lipscomb4, J. P. Leone5, A. Wiseman6, E. King4, A. J. Matas7, R. R. Alloway for the BEST Study Group4

    1Transplant Surgery, U of Cincinnati, Cincinnati, OH, 2UIC, Chicago, IL, 3Transplant Surgery, U of Wisconsin, Madison, WI, 4U of Cincinnati, Cincinnati, OH, 5Tampa General, Tampa, FL, 6U of Colorado, Denver, CO, 7U Minnesota, Minneapolis, MN

    *Purpose: Calcineurin inhibitor (CNI) and/or corticosteroid (CCS) therapy are associated with significant risk of new onset diabetes after transplantation (NODAT). An important consideration for simultaneous…
  • 2018 American Transplant Congress

    New Onset Diabetes after Kidney Transplant: Comparisons of Risks Associated with Various Steroid-Containing Calcineurin Inhibitor and Sirolimus Regimens

    A. Santos, Jr.,1 M. Casey,1 K. Alquadan,1 X. Wen,2 C. Chen,3 A. Gutierrez-Mena,1 K. Womer.1

    1College of Medicine, Univ. of Florida, Gainesville, FL; 2College of Pharmacy, Univ. of Rhode Island, Kingston, RI; 3College of Pharmacy, Univ. of Florida, Gainesville, FL.

    INTRODUCTION: We aimed to examine the risk of new onset diabetes after transplant (NODAT) associated with the following maintenance immunosuppression regimens in kidney transplant recipients…
  • 2018 American Transplant Congress

    Outcomes in Renal Transplant Recipients with Bipolar Disorder: A Large Retrospective Cohort

    S. Hamel,1 D. Sawinski,2 R. Weinrieb,3 S. Dave,3 J. Trofe-Clark.1,2

    1Pharmacy, Hosp of Univ. of Pennsylvania, Philadelphia; 2Renal Division, Perelman School of Medicine, Univ. of Pennsylvania, Philadelphia; 3Dept of Psychiatry, Perelman School of Medicine, Univ. of Pennsylvania, Philadelphia.

    Purpose: Management of renal transplant recipients (RTRs) with bipolar disorder (BD) is complicated by risk factors for non-adherence, complex medication regimens and limited published guidance.…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences